These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 26261543)
1. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy. Ran X; Yang J; Liu C; Zhou P; Xiao L; Zhang K Int J Clin Exp Pathol; 2015; 8(6):6617-26. PubMed ID: 26261543 [TBL] [Abstract][Full Text] [Related]
2. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma. Li L; Shou H; Wang Q; Liu S Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067 [TBL] [Abstract][Full Text] [Related]
3. Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel. Lang B; Shang C; Meng L Med Sci Monit; 2016 Jun; 22():1953-8. PubMed ID: 27279639 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. Shi Y; Gong W; Lu L; Wang Y; Ren J Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305 [TBL] [Abstract][Full Text] [Related]
5. miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Li X; Wang S; Chen Y; Liu G; Yang X Tumour Biol; 2014 Jun; 35(6):6021-8. PubMed ID: 24609901 [TBL] [Abstract][Full Text] [Related]
6. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Chatterjee A; Chattopadhyay D; Chakrabarti G Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
8. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression. Chatterjee A; Chattopadhyay D; Chakrabarti G PLoS One; 2014; 9(4):e95716. PubMed ID: 24755562 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis. Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072 [TBL] [Abstract][Full Text] [Related]
10. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P; Liu WL Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792 [TBL] [Abstract][Full Text] [Related]
11. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy. Chen Y; Zhou X; Qiao J; Bao A Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045 [TBL] [Abstract][Full Text] [Related]
12. miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Guo S; Bai R; Liu W; Zhao A; Zhao Z; Wang Y; Wang Y; Zhao W; Wang W Tumour Biol; 2014 Jul; 35(7):7025-34. PubMed ID: 24752578 [TBL] [Abstract][Full Text] [Related]
13. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2). Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538 [TBL] [Abstract][Full Text] [Related]
15. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells. Zhuo Z; Yu H Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207 [TBL] [Abstract][Full Text] [Related]
16. miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2. Wang C; Liu B Arch Gynecol Obstet; 2018 Jun; 297(6):1539-1548. PubMed ID: 29691644 [TBL] [Abstract][Full Text] [Related]
17. H19/miR-107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing autophagy in vitro and in vivo. Chen L; Xu Z; Zhao J; Zhai X; Li J; Zhang Y; Zong L; Peng H; Qi J; Kong X; Fang Z; Liu M Cell Biol Int; 2021 Mar; 45(3):674-685. PubMed ID: 33314408 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3. Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917 [TBL] [Abstract][Full Text] [Related]
19. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488 [TBL] [Abstract][Full Text] [Related]
20. Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel. Chen K; Shi W Tumour Biol; 2016 Aug; 37(8):10539-44. PubMed ID: 26852748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]